Intrinsic Value

Is BLS undervalued or overvalued?

See the intrinsic value estimate for Bioxyne Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

BLS Intrinsic Value
LOCKED
Unlock
Today vs. history

BLS looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with BLS’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor BLS
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price AU$1.09
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to BLS

Fundamental Analysis

What Bioxyne Does

Consumer products Consumer Staples

Bioxyne Ltd is an Australian healthcare company that makes and sells cannabis-based medicines, probiotics, and dietary supplements. It sits in the middle of the health products chain: it develops formulas, sources ingredients, and turns them into finished products that can be sold through pharmacies, clinics, distributors, and other health channels.

Headquarters
Australia AU
IPO date
Dec 14, 2000
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Bioxyne Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one BLS stock?

The intrinsic value for Bioxyne Ltd (BLS) under the Base Case is hidden AUD.

Is BLS stock undervalued or overvalued?

Compared with the current market price of 1.085 AUD, the stock appears hidden.

Back to Top